Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet transfusions in infants with necrotizing enterocolitis.

Caraciolo J Fernandes1, Donough J O'Donovan

  • 1Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, TX 77030, USA. fernande@bcm.edu

Current Hematology Reports
|March 16, 2006
PubMed
Summary

Platelet transfusions are common in premature infants with necrotizing enterocolitis (NEC) and low platelets, but may worsen inflammation. This review examines the role of platelet activating factor (PAF) in NEC and transfusion risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictors of challenging initial intubation and association with outcomes in congenital diaphragmatic hernia.

Journal of perinatology : official journal of the California Perinatal Association·2026
Same author

Association between vasoactive-inotropic score, clinical outcomes, defect size and laterality in congenital diaphragmatic hernia.

Journal of perinatology : official journal of the California Perinatal Association·2026
Same author

A novel approach to calculating expected total fetal lung volume in fetuses with isolated congenital diaphragmatic hernia and fetal growth restriction: a theoretical computational simulation.

Journal of perinatal medicine·2025
Same author

Impact of Neonatal Ventilation Mode on Outcomes in Patients With Congenital Diaphragmatic Hernia Treated With Extracorporeal Life Support: A Propensity Score Analysis.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2025
Same author

Early Use Experience of the Crescent Right Atrial Cannula for Neonatal Veno-Venous Extracorporeal Membrane Oxygenation.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2025
Same author

Infantile myofibromatosis: Small bumps pose big problems.

Journal of neonatal-perinatal medicine·2025

Area of Science:

  • Neonatalogy
  • Pediatric Gastroenterology
  • Hematology

Background:

  • Severe thrombocytopenia (platelet count < 50 x 10(9)/L) is common in advanced necrotizing enterocolitis (NEC).
  • Platelet transfusions are frequently administered to premature infants with severe thrombocytopenia to prevent hemorrhage, despite limited supporting evidence.
  • Platelet transfusions contain bioactive factors, such as platelet activating factor (PAF), which may exacerbate systemic inflammation.

Purpose of the Study:

  • To review the potential roles of platelet activating factor (PAF) and platelet transfusions in the pathogenesis and management of severe necrotizing enterocolitis (NEC) in infants.
  • To discuss the association between severe thrombocytopenia, platelet transfusions, and mortality in infants with NEC.

Main Methods:

  • Literature review of existing animal and human data.

Related Experiment Videos

  • Analysis of the role of platelet activating factor (PAF) in necrotizing enterocolitis (NEC) pathogenesis.
  • Examination of the association between platelet transfusions and outcomes in infants with severe NEC.

    • Main Results:

    • Evidence suggests platelet activating factor (PAF) plays a role in the pathogenesis of necrotizing enterocolitis (NEC).
    • Both severe thrombocytopenia and multiple platelet transfusions have been linked to increased mortality in infants with NEC.
    • Distinguishing the effects of underlying NEC from potential adverse effects of platelet transfusions is challenging.

    Conclusions:

    • Platelet transfusions in infants with severe necrotizing enterocolitis (NEC) may carry risks due to bioactive factors like PAF.
    • Further research is needed to clarify the benefits versus risks of platelet transfusions in this vulnerable population.
    • Understanding the role of PAF is crucial for developing targeted therapies for NEC.